The Johns Hopkins Center for Immunization Research is looking for healthy volunteers to participate in an inpatient shigella vaccine study. The study has both an outpatient and inpatient portion. The purpose of this study is to find out if an experimental bioconjugate vaccine targeting four strains of shigella, called Shigella4V2, protects people from getting sick from shigella. If you are between the ages of 18 and 50, you may be eligible to participate. The study is around seven months long, not including screening and requires the following:
- Approximately 2 screening visits
- 3 in-person visits
- 1 admission
- 2 phone calls
Eligible people will be compensated up to $4,420 for participation. For more information, call 410-955-SAVE (7283) or visit the CIR website.
OR
To see if you qualify for in-person screening, go here to complete the pre-screening survey.
Principal Investigator: Kawsar Talaat, MD
